FIBROSIS

Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD
Mustafa Al-Karaghouli, Sonia Fuentes, Tracy Davyduke, Mang Ma, Juan G Abraldes

BMJ Open Gastroenterology Jan 2022, 9 (1) e000798; DOI: 10.1136/bmjgast-2021-000798
Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
Sara Naimimohasses, Philip O'Gorman, Emma McCormick, Damien Ferguson, Ann Monaghan, Marie McGrath, Mark W Robinson, John Gormley, Suzanne Norris

BMJ Open Gastroenterology May 2022, 9 (1) e000861; DOI: 10.1136/bmjgast-2021-000861
Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan)
Azhar Hussain, Muhammad Asif Gul, Muhammad Usama Khalid

BMJ Open Gastroenterology Oct 2019, 6 (1) e000316; DOI: 10.1136/bmjgast-2019-000316
Endoscopic treatment of Crohn-related strictures with a self-expandable stent compared with balloon dilation: a prospective, randomised, controlled study
Per Hedenström, Per-Ove Stotzer

BMJ Open Gastroenterology Mar 2021, 8 (1) e000612; DOI: 10.1136/bmjgast-2021-000612
Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
Philip O'Gorman, Suzanne Norris

BMJ Open Gastroenterology Jun 2021, 8 (1) e000568; DOI: 10.1136/bmjgast-2020-000568
Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)
Pegah Golabi, Maria Stepanova, Huong T Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi

BMJ Open Gastroenterology Mar 2018, 5 (1) e000198; DOI: 10.1136/bmjgast-2018-000198
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
Fabio Nascimbeni, Judith Aron-Wisnewsky, Raluca Pais, Joan Tordjman, Christine Poitou, Frederic Charlotte, Pierre Bedossa, Thierry Poynard, Karine Clément, Vlad Ratziu, for the LIDO study Group

BMJ Open Gastroenterology Mar 2016, 3 (1) e000075; DOI: 10.1136/bmjgast-2015-000075
Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials
Brittany E Yee, Nghia H Nguyen, Minjuan Jin, Glen Lutchman, Joseph K Lim, Mindie H Nguyen

BMJ Open Gastroenterology Mar 2016, 3 (1) e000056; DOI: 10.1136/bmjgast-2015-000056

Log in using your username and password

Main menu

Log in using your username and password

You are here

FIBROSIS